Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium.
Obermayr E, Mohr T, Schuster E, Braicu EI, Taube E, Sehouli J, Vergote I, Pujade-Lauraine E, Ray-Coquard I, Harter P, Wimberger P, Joly-Lobbedez F, Mahner S, Moll UM, Concin N, Zeillinger R. Obermayr E, et al. Among authors: schuster e. Int J Cancer. 2024 Apr 27. doi: 10.1002/ijc.34978. Online ahead of print. Int J Cancer. 2024. PMID: 38676430
Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.
Hofstetter G, Berger A, Schuster E, Wolf A, Hager G, Vergote I, Cadron I, Sehouli J, Braicu EI, Mahner S, Speiser P, Marth C, Zeimet AG, Ulmer H, Zeillinger R, Concin N. Hofstetter G, et al. Among authors: schuster e. Br J Cancer. 2011 Nov 8;105(10):1593-9. doi: 10.1038/bjc.2011.433. Epub 2011 Oct 18. Br J Cancer. 2011. PMID: 22009029 Free PMC article.
Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
Pils D, Hager G, Tong D, Aust S, Heinze G, Kohl M, Schuster E, Wolf A, Sehouli J, Braicu I, Vergote I, Cadron I, Mahner S, Hofstetter G, Speiser P, Zeillinger R. Pils D, et al. Among authors: schuster e. Cancer Sci. 2012 Jul;103(7):1334-41. doi: 10.1111/j.1349-7006.2012.02306.x. Epub 2012 May 17. Cancer Sci. 2012. PMID: 22497737 Free PMC article.
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium.
Pils D, Tong D, Hager G, Obermayr E, Aust S, Heinze G, Kohl M, Schuster E, Wolf A, Sehouli J, Braicu I, Vergote I, Van Gorp T, Mahner S, Concin N, Speiser P, Zeillinger R. Pils D, et al. Among authors: schuster e. BMC Cancer. 2013 Apr 3;13:178. doi: 10.1186/1471-2407-13-178. BMC Cancer. 2013. PMID: 23551967 Free PMC article.
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium.
Bachmayr-Heyda A, Aust S, Heinze G, Polterauer S, Grimm C, Braicu EI, Sehouli J, Lambrechts S, Vergote I, Mahner S, Pils D, Schuster E, Thalhammer T, Horvat R, Denkert C, Zeillinger R, Castillo-Tong DC. Bachmayr-Heyda A, et al. Among authors: schuster e. BMC Cancer. 2013 Sep 17;13:422. doi: 10.1186/1471-2407-13-422. BMC Cancer. 2013. PMID: 24044611 Free PMC article.
Prognostic significance of circulating tumor cells and tumor related transcripts in small cell lung cancer: A step further to clinical implementation.
Welsch E, Holzer B, Schuster E, Fabikan H, Weinlinger C, Hauptmann-Repitz E, Illini O, Hochmair MJ, Fischer MB, Weiss E, Zeillinger R, Obermayr E. Welsch E, et al. Among authors: schuster e. Int J Cancer. 2024 Jun 15;154(12):2189-2199. doi: 10.1002/ijc.34886. Epub 2024 Feb 14. Int J Cancer. 2024. PMID: 38353516
372 results